Meeting
2021 ASCO Annual Meeting
Real-world utilization of advanced therapies and racial disparity among patients with metastatic castration-sensitive prostate cancer (mCSPC): A Medicare database analysis.
Authors
Stephen J. Freedland
Cedars-Sinai Medical Center, Los Angeles, CA
Stephen J. Freedland , Neeraj Agarwal , Krishnan Ramaswamy , Rickard Sandin , Dave Russell , Agnes Hong , Hongbo Yang , Wei Gao , Kaitlin Hagan , Daniel J. George
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Hormone-Sensitive
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5073)
DOI
10.1200/JCO.2021.39.15_suppl.5073
Abstract #
5073
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Real-world first-line (1L) treatment patterns in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in a U.S. health insurance database.
First Author: Umang Swami
Poster
2021 ASCO Annual Meeting
Real-world treatment patterns among patients diagnosed with metastatic castration-sensitive prostate cancer (mCSPC) in community oncology settings.
First Author: Daniel J. George
Poster
2024 ASCO Genitourinary Cancers Symposium
Survival Outcomes of APA as a Starting treatment: Impact in real-world patients with mCSPC (OASIS)
First Author: Benjamin L. Maughan
Poster
2024 ASCO Genitourinary Cancers Symposium
Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.
First Author: Sreevalsa Appukkuttan